文献速递眼整形与眼眶神经眼科

静脉注射甲泼尼龙对甲状腺眼病患者血清抗体水平的影响

Effect of intravenous methylprednisolone on serum antibody levels in thyroid eye disease.
PubMed 文献 · Br J Ophthalmol · 2025-03-20

这项单中心回顾性观察研究纳入163例中重度甲状腺眼病患者并随访12个月,比较接受与未接受静脉注射甲泼尼龙(IVMP)患者的纵向自身抗体变化。IVMP组TSH受体抗体滴度前6个月快速下降、之后缓慢下降至12个月时与对照组相近(组别与时间交互p=0.029),总胆固醇是激素反应的显著预后因素(OR 1.0217,95%CI 1.0068至1.0370,p=0.0043)。

要点

  • IVMP组TSH受体抗体滴度前6个月快速下降,之后缓慢下降至12个月时与对照组相似。
  • 组别与时间交互p=0.029,提示IVMP组与对照组抗体下降模式随时间不同。
  • 总胆固醇是激素反应的显著预后因素,OR 1.0217(95%CI 1.0068至1.0370),p=0.0043。

核心结论

  • IVMP在治疗后3个月内较未治疗组显著降低TSH受体抗体水平,但12个月后两组无显著差异。
  • 总胆固醇水平高的患者对IVMP反应通常较差。

研究设计与样本

  • 单中心、回顾性、观察性研究,纳入163例中重度甲状腺眼病患者并随访12个月。
  • 按是否接受IVMP分为治疗组和对照组,并按IVMP对TSH受体抗体水平的影响分为抗体下降组和抗体未下降组。
  • 采用广义估计方程评估12个月内时间、组别及交互作用与纵向自身抗体滴度的关联,采用多变量逻辑回归探究IVMP反应不良的预后因素。

主要发现

  • IVMP组TSH受体抗体滴度前6个月快速下降,之后缓慢下降至12个月,12个月时与对照组相似。
  • IVMP组与对照组抗体下降模式随时间不同(组别与时间交互p=0.029)。
  • 总胆固醇是激素反应的显著预后因素(OR 1.0217,95%CI 1.0068至1.0370,p=0.0043)。
  • 区分抗体下降组与抗体未下降组的总胆固醇阈值为186 mg/dL。

关键数值与推荐

  • 总胆固醇区分抗体下降与未下降的阈值为186 mg/dL。
  • 总胆固醇与激素反应关联的OR为1.0217(95%CI 1.0068至1.0370),p=0.0043。
  • 组别与时间交互p=0.029。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: We evaluated longitudinal autoantibody changes after intravenous methylprednisolone (IVMP), compared them with those in untreated patients and identified prognostic factors for treatment response. METHODS: In this single-centre, retrospective, observational study, a total of 163 individuals diagnosed with moderate-to-severe thyroid eye disease were enrolled and followed for 12 months. Depending on whether IVMP was administered, we divided the patients into treatment and control groups. Based on the effect of IVMP on TSH receptor (TSH Rc) antibody level, we divided the patients into Ab declined and Ab not declined groups.We evaluated the time, group and interaction associations with the longitudinal autoantibody titres over 12 months using generalised estimating equations. Using multivariable logistic regression, we investigated the prognostic factors for a poor response to IVMP. RESULTS: In the IVMP group, the TSH Rc antibody (Ab) titre decreased rapidly for 6 months and then decreased slowly until 12 months, becoming similar to the control group at 12 months. This suggests a difference in the decreasing pattern over time between the IVMP and control groups (group and time interaction p=0.029). Total cholesterol (OR 1.0217 (95% CI 1.0068 to 1.0370), p=0.0043) was a significant prognostic factor for the steroid response. The threshold total cholesterol value to distinguish between Ab declined and Ab not declined was 186 mg/dL. CONCLUSION: IVMP significantly decreased the TSH Rc Ab level for the 3 months after treatment, compared with the no-treatment group, but the groups did not differ significantly after 12 months. Patients with high total cholesterol levels generally showed a poor response to IVMP.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Lee C, Lee JE, Kim K, et al. Effect of intravenous methylprednisolone on serum antibody levels in thyroid eye disease. Br J Ophthalmol. 2025. PMID: 39251337. doi:10.1136/bjo-2024-325180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。